Corcept Therapeutics Price Chart
Corcept Therapeutics Volume Chart
Corcept Therapeutics Market Segments
After Hours
+0.00(+0.00%)
| Open | $114.49 |
|---|---|
| Close | $114.49 |
| Low | $114.49 |
| Low Change | 0.00 (0.00%) |
| High | $114.49 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 284.702K |
| Dollar Volume | $32.60M |
Regular Trading Hours
-3.63(-3.07%)
| Open | $118.11 |
|---|---|
| Close | $114.48 |
| Low | $111.79 |
| Low Change | -6.32 (-5.35%) |
| High | $118.53 |
| High Change | +0.42 (+0.36%) |
| Range | $6.74 |
| Volume | 1.548M |
| Dollar Volume | $177.26M |
Premarket
+0.00(+0.00%)
| Open | $118.50 |
|---|---|
| Close | $118.50 |
| Low | $118.50 |
| Low Change | 0.00 (0.00%) |
| High | $118.50 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 358 |
| Dollar Volume | $42.42K |
Overnight
*No Trades in Segment
After Hours Yesterday
-0.14(-0.12%)
| Open | $118.32 |
|---|---|
| Close | $118.18 |
| Low | $116.08 |
| Low Change | -2.24 (-1.89%) |
| High | $118.62 |
| High Change | +0.30 (+0.26%) |
| Range | $2.54 |
| Volume | 318.057K |
| Dollar Volume | $37.59M |
Regular Trading Hours Yesterday
+6.32(+5.64%)
| Open | $112.00 |
|---|---|
| Close | $118.32 |
| Low | $104.75 |
| Low Change | -7.25 (-6.47%) |
| High | $122.21 |
| High Change | +10.21 (+9.12%) |
| Range | $17.46 |
| Volume | 4.05M |
| Dollar Volume | $479.23M |
Premarket Yesterday
-2.37(-2.12%)
| Open | $112.05 |
|---|---|
| Close | $109.68 |
| Low | $105.00 |
| Low Change | -7.05 (-6.29%) |
| High | $116.45 |
| High Change | +4.40 (+3.93%) |
| Range | $11.45 |
| Volume | 105.458K |
| Dollar Volume | $11.57M |
Corcept Therapeutics News
2 days agobarrons.comS&P 500 Futures Rise in Premarket Trading; Corcept Therapeutics, FormFactor Lead
4 months agoinvesting.comCorcept Therapeutics stock surges on FDA cancer drug approval
- 4 months agoinvesting.com
Corcept Therapeutics stock gains after director stock purchase
- 5 months agoinvesting.com
Corcept Therapeutics stock falls after losing key patent case appeal
- 6 months agoinvesting.com
Corcept Therapeutics stock soars after cancer drug meets survival endpoint
- 7 months agoinvesting.com
Corcept Therapeutics stock plunges after FDA rejects hypercortisolism drug
7 months agobenzinga.comCorcept Therapeutics' Upcoming FDA Decision: Is A CRL Likely?
Corcept Therapeutics Top Trades
Corcept Therapeutics's top trade so far today returned +2.42%, while the top short trade returned -5.66%.
Corcept Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $98.38 |
|---|---|
| 10 Day Moving Average (SMA10) | $95.75 |
| 20 Day Moving Average (SMA20) | $93.36 |
| 50 Day Moving Average (SMA50) | $82.63 |
| 100 Day Moving Average (SMA100) | $62.96 |
| 200 Day Moving Average (SMA200) | $61.59 |
Corcept Therapeutics Statistics
| Average Volume (30 Days) | 1.12M |
|---|---|
| P/E Ratio (Current) | 216.16 |
| EPS (Current) | $0.43 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $119.79M |
| Cash Ratio | 0.73 |
| Current Ratio | 2.86 |
| Quick Ratio | 2.77 |
| Debt to Equity | 0.00 |
| Enterprise Value | $9.87B |
| EV to EBITDA | -1460.43 |
| EV to Sales | 12.83 |
| Price to Book | 15.64 |
| Price to Cash Flow | 83.09 |
| Price to Free Cash Flow | 83.30 |
| Price to Sales | 12.97 |
| Return on Assets | 0.06% |
| Return on Equity | 0.07% |
Corcept Therapeutics Stock Splits
There have been no stock splits for Corcept Therapeutics (CORT).
Corcept Therapeutics Dividends
There have been no dividends for Corcept Therapeutics (CORT).